NCT07751653 Evaluation of Three Different Antalgic Blocks in Total Knee Prosthesis
| NCT ID | NCT07751653 |
| Status | Recruiting |
| Phase | — |
| Sponsor | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio |
| Condition | Analgesia |
| Study Type | INTERVENTIONAL |
| Enrollment | 142 participants |
| Start Date | 2026-08-06 |
| Primary Completion | 2027-02-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 142 participants in total. It began in 2026-08-06 with a primary completion date of 2027-02-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomised trial examines the three main anaesthetic blocks used in knee replacement surgery, comparing them in terms of analgesic efficacy (primary outcome), range of motion and degree of flexion in the immediate post-operative period. Other outcomes include medication use and an analysis of any differences based on sex and age.
Eligibility Criteria
Inclusion Criteria: * Total Knee prosthesis * ASAC I-II * signed Informed consent form Exclusion Criteria: * \<40 years * Mental confusion and delirium * Coagulation disorders
Frequently Asked Questions
Who can join the NCT07751653 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Analgesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07751653 currently recruiting?
Yes, NCT07751653 is actively recruiting participants. Visit ClinicalTrials.gov or contact I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio to inquire about joining.
Where is the NCT07751653 trial being conducted?
This trial is being conducted at Milan, Italy, Milan, Italy.
Who is sponsoring the NCT07751653 clinical trial?
NCT07751653 is sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio. The trial plans to enroll 142 participants.